PRL-8-53
Cognitive · Obscure nootropic
Tier D
Bottom line
Read Off Label grades PRL-8-53 as D (3.3/10) based on very weak evidence, unclear benefit magnitude, and a unclear-risk safety profile.
Synthesized by Nikolaus Hansl at Creighton in the 1970s.
Typical use: No established modern dosing — Research chem.
What this is
Synthesized by Nikolaus Hansl at Creighton in the 1970s. The single human paper reported striking verbal memory improvement but was never replicated in 40+ years. Exemplar of a 'forgotten nootropic' with folkloric reputation and no modern data.
Mechanism
Benzhydryl-based compound; proposed cholinergic and dopaminergic potentiation; mechanism poorly characterized
Dose & route
No established modern dosing
Citations
- https://pubmed.ncbi.nlm.nih.gov/686364/
- https://patents.google.com/patent/US3870719A/en
- https://pubmed.ncbi.nlm.nih.gov/693019/
Links go to the source. If a link is dead or you want something re-checked, let me know.
Common questions
- Does PRL-8-53 work?
- Read Off Label rates the evidence for PRL-8-53 as Very Weak and the benefit magnitude as unclear, producing an overall grade of D (3.3/10). Synthesized by Nikolaus Hansl at Creighton in the 1970s.
- Is PRL-8-53 safe?
- PRL-8-53 has a unclear risk profile in published human data. Legal status: Research chem. This is not medical advice — see the disclaimer.
- What is the typical dose for PRL-8-53?
- No established modern dosing
- How does PRL-8-53 work?
- Benzhydryl-based compound; proposed cholinergic and dopaminergic potentiation; mechanism poorly characterized
This is an independent synthesis of published research by a non-clinician. Scores are opinions supported by citations, not prescriptions. See the full disclaimer and methodology for how this score was produced and what it does and doesn't mean.